1. Home
  2. NPO vs GRFS Comparison

NPO vs GRFS Comparison

Compare NPO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enpro Inc.

NPO

Enpro Inc.

N/A

Current Price

$300.61

Market Cap

6.3B

Sector

Industrials

ML Signal

N/A

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$7.57

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NPO
GRFS
Founded
2002
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.2B
IPO Year
2002
2008

Fundamental Metrics

Financial Performance
Metric
NPO
GRFS
Price
$300.61
$7.57
Analyst Decision
Buy
Hold
Analyst Count
3
2
Target Price
$278.33
$10.15
AVG Volume (30 Days)
126.3K
371.0K
Earning Date
05-05-2026
07-28-2022
Dividend Yield
0.46%
1.80%
EPS Growth
N/A
N/A
EPS
2.55
N/A
Revenue
$1,532,000,000.00
N/A
Revenue This Year
$12.31
$4.49
Revenue Next Year
$6.39
$6.42
P/E Ratio
$117.84
$18.67
Revenue Growth
16.98
N/A
52 Week Low
$202.00
$6.96
52 Week High
$390.42
$10.23

Technical Indicators

Market Signals
Indicator
NPO
GRFS
Relative Strength Index (RSI) 35.99 42.77
Support Level $259.63 $7.50
Resistance Level $286.35 $7.73
Average True Range (ATR) 9.73 0.14
MACD -0.27 -0.04
Stochastic Oscillator 2.30 9.26

Price Performance

Historical Comparison
NPO
GRFS

About NPO Enpro Inc.

Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through two segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies, which manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: